Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03089125 · ClinicalTrials.gov registry record · NA
Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 247
- Enrollment target
NCT03089125: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03089125 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 247 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03089125, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
Study Summary
This research study is evaluating a behavioral intervention designed to help people with advanced lung cancer manage dyspnea (i.e., breathlessness or shortness-of-breath).
Interventions
- OTHER Usual Care
- BEHAVIORAL Dyspnea Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2023-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03089125
The ClinicalTrials.gov registry entry for NCT03089125 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03089125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03089125 about?
NCT03089125 is a clinical study titled "Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer". This research study is evaluating a behavioral intervention designed to help people with advanced lung cancer manage dyspnea (i.e., breathlessness or shortness-of-breath).
What is the current status of trial NCT03089125?
This trial is currently completed. It is a NA study. The enrollment target is 247 participants. The study started on 2017-05-15. Estimated completion is 2023-04-06.
What interventions are being tested in trial NCT03089125?
The interventions under investigation include: Usual Care (OTHER), Dyspnea Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03089125?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.